KEAP1 and brain neoplasm: Emerging evidence reveals that modulating Nrf2/ARE and downstream antioxidant enzymes in a Keap1-dependant manner, with the aid of multiple plant-derived secondary metabolites might play pivot in the management of brain tumors [6].